Study Solutions
Leading reason for long-term care placement ANS incontinence
incontinence increases ANS skin breakdown and falls
Higher incontinence rate when younger than 85 ANS women
Incontinence rate for men and women 85+ ANS similar
Overactive bladder ANS Urgency, frequency, and nocturia
Incontinence risk factors ANS assistance ambulating, female, walker, obesity, diabetes, depression,
hysterectomy, neuro impairment, cognitive impairment, dementia, and fecal incontinence
Stress incontinence ANS leakage with exertion like coughing sneezing laughing
Diagnostic tests for urinary incontinence ANS Pelvic: r/o mass, mobile urethra, cystocele, rectocle.
Urinalysis: r/o UTI/hematuria
Empty supine stress test: void then observe urethra in lithotomy while bearing down
Diagnostic test for overflow incontinence ANS PVR
Positive supine empty stress test ANS intrinsic urethral sphincter dysfunction. Tx includes kegel exercises
and antimuscarinic med
First line med stress incontinence ANS antimuscarinic med: oxybutynin
Behavioral therapies for what type of incontinence ANS urgency and stress
, Incontinence behavioral therapies include ANS bladder training frequent voiding every 2 hours and pelvic
exercises
UTI in older adults ANS most common bacterial infection in adults over 65 and most common cause of
sepsis
Older adults community UTI ANS dysuria, urgency, hematuria
postmenopausal: incontinence, nocturia, low back pain, constipation
Older adults: cognition and confusion
Older adult UTI: community ANS treatment not based on symptoms can be another disease so do a
dipstick if + nitrates and + leukocytes treat
Older adult UTI: long term care ANS frequency, nocturia, incontinence and changes in mental state is very
common
McGeer Criteria ANS Acute dysuria or fever (37.9) >100 with urgency, frequency, suprapubic pain, gross
hematuria, cva tenderness, incontinence
Loeb Criteria ANS fever > (38) 100, new dysuria, frequency, urgency, pain, character of urine change,
mental status change (need 3)
UTI first line treatment ANS Nitrofurantoin 100mg BID x 5 days and Trimethoprim/sulfamethoxazole
800/160mg PO BID x 7 days
Benign prostatic hyperplasia ANS smooth muscle hyperplasia, prostate enlargement, bladder dysfunction
r/t CNS
BPH: leads to what type of symptoms ANS lower urinary tract symptoms r/t urethra narrowing and
obstructing flow from bladder
BPH most common risk factor ANS age